Cataract Clinical Trial
Official title:
Anterior Chamber Depth (ACD) Variability Between the Clareon and Acrysof IOL: a Randomised Trial
Compare the change of the Anterior chamber depth (ACD) variability between the Clareon and the AcrySof Intraocular lens (IOL) after implantation over 6 months.
Patients undergoing cataract surgery are often otherwise healthy and active with their only
restriction being reduced visual quality. Within the past few years, intraocular lenses
(IOLs) have been improved to fulfill the needs of these patients. Nowadays efforts are aiming
for the enhancement of the patient vision and his subjective satisfaction postoperative.
One of the best ways to accomplish this is to have a perfect intraocular lens (IOL) power
calculation. However, the best calculation can't help if the implanted intraocular lens (IOL)
changes its position after implantation.
It should be considered that an anterior chamber depth (ACD) shift, decentration, tilt or
rotation of an IOL could result in a reduction in visual quality. For an aspherical IOL, for
instance, it is essential not to be decentrated and tilted more than 0.4 mm 2 (0.8 mm 3) and
7° 2 (10° 3), respectively. Otherwise it will be outperformed by a spherical IOL. The
estimation of the post-operative intraocular lens (IOL) position and therefore the estimated
anterior chamber depth (ACD) is presently the main source of error (35% 4 to 42% 5) in IOL
power calculation and therefore for the refractive outcome of the patients after cataract
surgery. Presently the pre-operatively measured ACD is taken into account for several IOL
power calculation formulas, such as the Haigis formula, the Holladay II formula and the Olsen
formula.
To manage a better outcome an IOL with less postoperative influence of the anterior chamber
depth (ACD) is very important. To accomplish a smaller deviation after the operation of the
anterior chamber depth (ACD) the haptic and the material of the lens is very important. The
change of the anterior chamber depth (ACD) after cataract surgery can be easily measured by
instruments like the IOL-Master 700, AC-Master and Lenstar. It must be considered that every
person is different and that change of the anterior chamber depth (ACD) in different eyes can
cause high measurement errors. The changes in two eyes of the same patient help to minimize
the error. These can help to achieve a better outcome for future patients.
The hydrophobic acrylate of the Acrysof IOL has been modified to the new material in the
Clareon IOL. This study will evaluate whether the new Clareon has non-inferior axial
stability to the Acrysof.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04685538 -
Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification.
|
Phase 3 | |
Recruiting |
NCT06060041 -
IC-8 Apthera IOL New Enrollment Post Approval Study
|
||
Recruiting |
NCT05518539 -
Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
|
||
Recruiting |
NCT05271942 -
Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods
|
N/A | |
Active, not recruiting |
NCT04778501 -
PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia
|
N/A | |
Completed |
NCT05062564 -
Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye
|
N/A | |
Completed |
NCT03751033 -
Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings
|
N/A | |
Completed |
NCT02529488 -
Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00
|
N/A | |
Completed |
NCT04539548 -
A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract
|
Phase 3 | |
Completed |
NCT03740659 -
Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery
|
Phase 2 | |
Completed |
NCT03494257 -
Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification
|
N/A | |
Completed |
NCT05119127 -
Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome.
|
N/A | |
Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
Recruiting |
NCT03713268 -
Intraoperative OCT Guidance of Intraocular Surgery II
|
||
Completed |
NCT03739528 -
Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery
|
Phase 3 | |
Completed |
NCT02888210 -
A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery
|
Phase 3 | |
Completed |
NCT03356847 -
Evaluation of the Rotational Stability of the Monofocal SISA Implant Following Cataract Surgery
|
N/A | |
Completed |
NCT04332640 -
Clinical Evaluation of the Next Generation Phaco System
|
N/A | |
Recruiting |
NCT03638726 -
Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification
|
Phase 4 | |
Completed |
NCT03050697 -
Evaluation of the Safety and Performance of the HARMONI® Toric Lens
|
N/A |